Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia

Journal of Molecular Diagnostics

Volumn 16, Issue 4, 2014, Pages 382-392

  Kristensen, Thomas ^a   Larsen, Martin ^a,b   Rewes, Annika ^a   Frederiksen, Henrik ^a   Thomassen, Mads ^a,b   Møller, Michael Boe ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOSTATIN; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MINIMAL RESIDUAL DISEASE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VERY ELDERLY; EVALUATION STUDY; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; MUTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAT3 TRANSCRIPTION FACTOR;

EID: 84902995583     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.02.005     Document Type: Article

References (23)

1. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, and J.W. Vardiman WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Lyon 272 273
2. T. Lamy, and T.P. Loughran Jr. How I treat LGL leukemia Blood 117 2011 2764 2774
3. H.L. Koskela, S. Eldfors, P. Ellonen, A.J. van Adrichem, H. Kuusanmaki, E.I. Andersson, S. Lagstrom, M.J. Clemente, T. Olson, S.E. Jalkanen, M.M. Majumder, H. Almusa, H. Edgren, M. Lepisto, P. Mattila, K. Guinta, P. Koistinen, T. Kuittinen, K. Penttinen, A. Parsons, J. Knowles, J. Saarela, K. Wennerberg, O. Kallioniemi, K. Porkka, T.P. Loughran Jr., C.A. Heckman, J.P. Maciejewski, and S. Mustjoki Somatic STAT3 mutations in large granular lymphocytic leukemia N Engl J Med 366 2012 1905 1913
4. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan, Y. Zhao, R.G. Pestell, C. Albanese, and J.E. Darnell Jr. Stat3 as an oncogene Cell 98 1999 295 303
5. A. Jerez, M.J. Clemente, H. Makishima, H. Koskela, F. Leblanc, N.K. Peng, T. Olson, B. Przychodzen, M. Afable, I. Gomez-Segui, K. Guinta, L. Durkin, E.D. Hsi, K. McGraw, D. Zhang, M.W. Wlodarski, K. Porkka, M.A. Sekeres, A. List, S. Mustjoki, T.P. Loughran, and J.P. Maciejewski STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia Blood 120 2012 3048 3057
6. A. Fasan, W. Kern, V. Grossmann, C. Haferlach, T. Haferlach, and S. Schnittger STAT3 mutations are highly specific for large granular lymphocytic leukemia Leukemia 27 2013 1598 1600
7. R.S. Ohgami, L. Ma, J.D. Merker, B. Martinez, J.L. Zehnder, and D.A. Arber STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia Leukemia 27 2013 2244 2247
8. Z.Y. Qiu, L. Fan, L. Wang, C. Qiao, Y.J. Wu, J.F. Zhou, W. Xu, and J.Y. Li STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia J Hematol Oncol 6 2013 82
9. J.J. van Dongen, A.W. Langerak, M. Bruggemann, P.A. Evans, M. Hummel, F.L. Lavender, E. Delabesse, F. Davi, E. Schuuring, R. Garcia-Sanz, J.H. van Krieken, J. Droese, D. Gonzalez, C. Bastard, H.E. White, M. Spaargaren, M. Gonzalez, A. Parreira, J.L. Smith, G.J. Morgan, M. Kneba, and E.A. Macintyre Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 2003 2257 2317
10. M.L. Metzker Sequencing technologies - the next generation Nat Rev Genet 11 2010 31 46
11. A. Kohlmann, V. Grossmann, N. Nadarajah, and T. Haferlach Next-generation sequencing - feasibility and practicality in haematology Br J Haematol 160 2013 736 753
12. A.W. Langerak, P.J. Groenen, M. Bruggemann, K. Beldjord, C. Bellan, L. Bonello, E. Boone, G.I. Carter, M. Catherwood, F. Davi, M.H. Delfau-Larue, T. Diss, P.A. Evans, P. Gameiro, S.R. Garcia, D. Gonzalez, D. Grand, A. Hakansson, M. Hummel, H. Liu, L. Lombardia, E.A. Macintyre, B.J. Milner, S. Montes-Moreno, E. Schuuring, M. Spaargaren, E. Hodges, and J.J. van Dongen EuroClonality/ BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations Leukemia 26 2012 2159 2171
13. A. Untergasser, I. Cutcutache, T. Koressaar, J. Ye, B.C. Faircloth, M. Remm, and S.G. Rozen Primer3 - new capabilities and interfaces Nucleic Acids Res 40 2012 e115
14. H. Li, and R. Durbin Fast and accurate short read alignment with Burrows-Wheeler transform Bioinformatics 25 2009 1754 1760
15. D.C. Koboldt, Q. Zhang, D.E. Larson, D. Shen, M.D. McLellan, L. Lin, C.A. Miller, E.R. Mardis, L. Ding, and R.K. Wilson VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing Genome Res 22 2012 568 576
16. A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M.A. DePristo The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 2010 1297 1303
17. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, and R. Durbin The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2009 2078 2079
18. A. Jerez, M.J. Clemente, H. Makishima, H. Rajala, I. Gomez-Segui, T. Olson, K. McGraw, B. Przychodzen, A. Kulasekararaj, M. Afable, H.D. Husseinzadeh, N. Hosono, F. Leblanc, S. Lagstrom, D. Zhang, P. Ellonen, A. Tichelli, C. Nissen, A.E. Lichtin, A. Wodnar-Filipowicz, G.J. Mufti, A.F. List, S. Mustjoki, T.P. Loughran Jr., and J.P. Maciejewski STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients Blood 122 2013 2453 2459
19. C.S. Hourigan, and J.E. Karp Minimal residual disease in acute myeloid leukaemia Nat Rev Clin Oncol 10 2013 460 471
20. V. Grossmann, A. Roller, H.U. Klein, S. Weissmann, W. Kern, C. Haferlach, M. Dugas, T. Haferlach, S. Schnittger, and A. Kohlmann Robustness of amplicon deep sequencing underlines its utility in clinical applications J Mol Diagn 15 2013 473 484
21. P. Keohavong, and W.G. Thilly Fidelity of DNA polymerases in DNA amplification Proc Natl Acad Sci U S A 86 1989 9253 9257
22. F. Thol, B. Kolking, F. Damm, K. Reinhardt, J.H. Klusmann, D. Reinhardt, N. von Neuhoff, M.H. Brugman, B. Schlegelberger, S. Suerbaum, J. Krauter, A. Ganser, and M. Heuser Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations Genes Chromosomes Cancer 51 2012 689 695
23. D.H. Spencer, H.J. Abel, C.M. Lockwood, J.E. Payton, P. Szankasi, T.W. Kelley, S. Kulkarni, J.D. Pfeifer, and E.J. Duncavage Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data J Mol Diagn 15 2013 81 93